New Findings Reported from St. Jude Children's Research Hospital Describe Advances in Solid Cancer (Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with ...)

Source :: Immunotherapy Weekly. May 27, 2020, 294
Publication Year :: 2020
Abstract: 2020 MAY 27 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Data detailed on Oncology - Solid Cancer have been presented. According to news reporting out [...]

Subjects :: Cyclophosphamide -- Dosage and administration
Cancer -- Analysis
Bevacizumab -- Dosage and administration
Cancer research -- Analysis
Vascular endothelial growth factor -- Analysis
Sorafenib -- Dosage and administration
Immunotherapy -- Analysis
Platelet-derived growth factor -- Analysis
Charities
Antineoplastic agents
Endothelial growth factors
Syrian foreign relations
Tumors
Endothelium
Cancer metastasis
Editors
Lebanese foreign relations
Health

Tools